| General Information | |||
|---|---|---|---|
| Term | apparent mineralocorticoid excess syndrome | ID (Ontology) | DOID:4367 (Human Disease) |
| Definition | A steroid inherited metabolic disorder characterized by decreased conversion of biologically active cortisol to inactive cortisone resulting in low aldosterone levels, metabolic alkalosis, hypernatremia, hypokalemia and early-onset severe hypertension that has_material_basis_in homozygous or compound heterozygous mutation in the HSD11B2 gene on chromosome 16. | ||
| Also Known As | "11-beta-hydroxysteroid dehydrogenase deficiency type 2" ; "cortisol 11-beta-ketoreductase deficiency" ; "syndrome of apparent mineralocorticoid excess" (for all, see Synonyms field below) | ||
| Comment | |||
| Links to External Ontologies | |||
| DO.org | |||
| Annotations | |||
| Records annotated with this term OR any of its CHILD TERMS | |||
Full annotation statements including this term (annotations to child terms are NOT included), and relevant FlyBase records
|
|||
|
||||||
lipid metabolism disorder |__steroid inherited metabolic disorder |__apparent mineralocorticoid excess syndrome 2 rec. |
| Spanning Tree View Settings | |||
|---|---|---|---|
| Parents/Children View Depth |
|||
Relationships
|
|||
| Is a | steroid inherited metabolic disorder | ||
| Part of | |||
Synonyms & Secondary IDs
|
|||
| Synonyms | |||
|
|||
| Secondary IDs | |||
|
|
|||
External Crossreferences & Linkouts
|
|||
|
GARD:433 MESH:D043204 MIM:218030 NCI:C123231 ORDO:320 SNOMEDCT_US_2023_03_01:237770005 UMLS_CUI:C0342488 |
|||